Objective
OBTAIN A PROCEDURE FOR EVALUATING IN VITRO OF CERTAINS IMMUNOTOXIC EFFECTS OF CHEMICAL SUBSTANCES.
Molecular biological analysis at the level of cytokine gene expression has been studied as a method for determining the immunomodulatory potential of drugs and industrial chemicals. Studies were carried out to establish whether a correlation existed between conventional functional assays and the analysis of cytokine messenger ribonucleic acid (mRNA) levels in specific immune cell populations (primarily macrophages and T lymphocytes). Effects of well defined pharmaceutical compounds known to enhance or suppress immune responses in vivo were determined in in vitro cell culture systems, or, in some instances, in cells obtained after in vivo exposure. In vitro experiments showed that 3 immunomodulatory agents, biostim, cyclosporin A and gelonin, modulated the expression of specific immune genes, which was in keeping with alterations in production of cytokines as assessed in parallel experiments. The immunopotentiating effect of biostim on macrophage populations at both the mRNA and protein levels was clearly demonstrated in both systems. The expression of mRNA for inteurleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-6 and tumour necrosis factor alpha (TNF-alpha) could be elevated by concentrations as low as 1-10 pg/ml, whereas functional assays were 100-fold less sensitive. An easy to perform and economical functional assay for IL-1 activity, however, was a great improvement over the conventionally performed assay system. The immunosuppressive effects of cyclosporin A on T-lymphocyte activity was clearly evident in both functional and molecular biological assays; the latter was 10-fold more sensitive and changes were detected at an earlier time point. Correlations between molecular biological and functional assays have thus been established.
THE EFFECTS OF THE ADMINISTRATION OF SPECIFIC IMMUNODEPRESSIVE AGENTS INCLUDING DAUNORUBICIN, HYDROCORTISONE, CYCLOSPORIN A, MAFOSFAMIDE, SURAMIN AND GELONIN ON A SERIES OF IN VIVO AND EX VIVO IMMUNE PARAMETERS WILL BE EVALUATED IN C3H MICE AT THE MNI. IN VIVO TESTS WILL INCLUDE FOR EXAMPLE IL-1 RELEASE BY PERITONEAL MACROPHAGES AND QUANTITATIVE MHC EXPRESSION BY PURIFIED SPENIC T CELLS, WHILST MIXED LYMPHOCYTE REACTIONS AND MACROPHAGE MEDIATED CYTOTOXICITY ASSAYS WILL BE PERFORMED EX VIVO.IN ADDITION, IN VIVO DERIVED SUBCELLULAR FRACTIONS WILL BE PREPARED FROM VARIOUS CELL POPULATIONS FOR SPECIFIC M-RNA AND PROTEIN ANALYSIS AT BIBRA.THE DATA SO GENERATED WILL PROVIDE A DETAILED PROFILE OF THE GROSS IN VIVO IMMUNOTOXICOLOGICAL EFFECTS OF THESE AGENTS WHICH WILL BE RELATED TO THEIR INDUCED ALTERATIONS ON THE LEVEL OF EXPRESSION OF DEFINED IMMUNOREGULATORY GENES FOR EXAMPLE IL-1, IL-2 AND THEIR RESPECTIVE RECEPTORS.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences basic medicine immunology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Data not available
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Data not available
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
SM5 4DS Carshalton
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.